logo
logo
Sign in

Non-Alcoholic Steatohepatitis (Nash) Biomarkers Market Size and Growth Analysis with Trends, Key players & Outlook to 2030

avatar
Priyanshi Singh
Non-Alcoholic Steatohepatitis (Nash) Biomarkers Market Size and Growth Analysis with Trends, Key players & Outlook to 2030

The latest market report published by Credence Research, Inc. “Global Non-Alcoholic Steatohepatitis (Nash) Biomarkers Market: Growth, Future Prospects, and Competitive Analysis, 2016 – 2028. The global market for Non-alcoholic Steatohepatitis (Nash) Biomarkers has steadily risen in recent years and is predicted to increase at a CAGR of 23.10% between 2023 and 2030. The market was worth USD 0.91 billion in 2022 and is predicted to be around USD 3.91 billion by 2030.


Non-Alcoholic Steatohepatitis (NASH) has emerged as a significant health concern globally. NASH is a progressive form of Non-Alcoholic Fatty Liver Disease (NAFLD), characterized by hepatic inflammation and injury that can lead to fibrosis, cirrhosis, and even hepatocellular carcinoma. Given the growing prevalence of NASH, the need for reliable and accurate biomarkers for its early diagnosis, prognosis, and monitoring has become paramount. In this article, we delve deep into the world of NASH biomarkers, exploring the current state of research, advancements, challenges, and potential breakthroughs.


Understanding NASH Biomarkers

NASH biomarkers are measurable substances in the body that indicate the presence, severity, or progression of NASH. These biomarkers can be in the form of proteins, lipids, enzymes, cytokines, or genetic markers. Accurate biomarkers play a crucial role in identifying patients at risk of developing NASH, facilitating timely intervention and personalized treatment plans.


Current Landscape of NASH Biomarker Research

The medical research community has been fervently investigating various potential NASH biomarkers to address the diagnostic and prognostic gaps. Liver biopsies have been the gold standard for NASH diagnosis, but they come with inherent risks and limitations. As a result, researchers have focused on non-invasive biomarkers that can provide reliable information without the need for invasive procedures.


State-of-the-Art Biomarkers for NASH

FibroTest: A composite biomarker panel that assesses the level of liver fibrosis, providing valuable insights into disease progression.


NAFLD Fibrosis Score: A non-invasive tool to evaluate the likelihood of advanced fibrosis in NAFLD and NASH patients.

Enhanced Liver Fibrosis (ELF) Test: An advanced blood test that measures key biomarkers associated with liver fibrosis.


Emerging Biomarkers with High Potential

miRNAs: MicroRNAs have shown promise as potential NASH biomarkers due to their regulatory roles in gene expression.

Oxidative Stress Markers: Biomarkers indicating oxidative stress in liver tissues may help in assessing disease severity.

Cytokeratin-18 (CK-18): An apoptotic biomarker that reflects hepatocyte death and has been studied for NASH prognosis.


Browse 200 pages report Non-Alcoholic Steatohepatitis (Nash) Biomarkers Market By Type (Serum Biomarkers, Hepatic Fibrosis Biomarkers, Apoptosis Biomarkers, Oxidative Stress Biomarkers, Others) By End-use (Pharma & CRO Industry, Hospitals, Diagnostic Labs, Academic Research Institutes)  - Growth, Future Prospects & Competitive Analysis, 2016 – 2030)- https://www.credenceresearch.com/report/non-alcoholic-steatohepatitis-nash-biomarkers-market


Future Prospects

The NASH biomarkers market is poised for remarkable growth, driven by increasing awareness, research funding, and advancements in diagnostic technologies. As novel biomarkers continue to emerge, healthcare professionals will gain better tools to identify NASH earlier, enabling timely interventions and improved patient outcomes.


Non-Alcoholic Steatohepatitis (NASH) Biomarkers Market Key Growth Trends: The Non-Alcoholic Steatohepatitis (NASH) biomarkers market is experiencing significant growth trends as the prevalence of NASH continues to rise globally. NASH, a progressive form of non-alcoholic fatty liver disease (NAFLD), has become a major public health concern due to its association with obesity, diabetes, and metabolic syndrome. This has created an urgent need for accurate diagnostic tools that can assess disease severity, predict progression, and evaluate treatment response. As a result, the demand for NASH biomarkers has surged in recent years.


Why to Buy This Report-

·        The report provides a qualitative as well as quantitative analysis of the global Non-Alcoholic Steatohepatitis (Nash) Biomarkers Market by segments, current trends, drivers, restraints, opportunities, challenges, and market dynamics with the historical period from 2016-2020, the base year- 2021, and the projection period 2022-2028.

·        The report includes information on the competitive landscape, such as how the market's top competitors operate at the global, regional, and country levels.

·        Major nations in each region with their import/export statistics

·        The global Non-Alcoholic Steatohepatitis (Nash) Biomarkers Market report also includes the analysis of the market at a global, regional, and country-level along with key market trends, major players analysis, market growth strategies, and key application areas.


Browse Full Report: https://www.credenceresearch.com/report/non-alcoholic-steatohepatitis-nash-biomarkers-market

Visit: https://www.credenceresearch.com/

Related Report: https://www.credenceresearch.com/report/polymerase-chain-reaction-pcr-market

Related Report: https://www.credenceresearch.com/report/respiratory-inhaler-devices-market

Browse Our Blog: https://www.linkedin.com/pulse/non-alcoholic-steatohepatitis-nash-biomarkers-market-grow-singh

Browse Our Blog: https://tealfeed.com/non-alcoholic-steatohepatitis-nash-biomarkers-market-bpn6l


About Us -

Credence Research is a viable intelligence and market research platform that provides quantitative B2B research to more than 10,000 clients worldwide and is built on the Give principle. The company is a market research and consulting firm serving governments, non-legislative associations, non-profit organizations, and various organizations worldwide. We help our clients improve their execution in a lasting way and understand their most imperative objectives. For nearly a century, we’ve built a company well-prepared for this task.


Contact Us:

Office No 3 Second Floor, Abhilasha Bhawan, Pinto Park, Gwalior [M.P] 474005 India


collect
0
avatar
Priyanshi Singh
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more